Salivary sIgA (mg/g saliva) declined over time in the placebo group, whereas reductions were less pronounced in probiotic-treated infants, although between-group differences were not clearly significant.
← all excerpts
Early-Life Microbiota Modulation and Neurodevelopment in Infants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
2
—
—
The sentences
Fecal sIgA (mg/g stool) showed a trend toward higher levels in the intervention group and lower levels in the placebo group, with one pre-specified subgroup demonstrating a significant difference in change-from-baseline (intervention +1.12 mg/g vs. placebo −1.02 mg/g).